Toll Free: 1-888-928-9744

Global Spinal Muscular Atrophy Market Size, Status and Forecast 2018-2025

Published: Oct, 2018 | Pages: 96 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

In 2017, the global Spinal Muscular Atrophy market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.

This report focuses on the global Spinal Muscular Atrophy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Spinal Muscular Atrophy development in United States, Europe and China.

The key players covered in this study
    Lonis Pharmaceuticals
    F. Hoffmann-La Roche
    AveXis
    Novartis
    Cytokinetics
    Ionis Pharmaceuticals
    ...

Market segment by Type, the product can be split into
    Early Stage Candidates
    Late Stage Candidates

Market segment by Application, split into
    Hospital
    Clinic
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Spinal Muscular Atrophy status, future forecast, growth opportunity, key market and key players.
    To present the Spinal Muscular Atrophy development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Spinal Muscular Atrophy are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
 Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Type (2013-2025)
        1.4.2 Early Stage Candidates
        1.4.3 Late Stage Candidates
    1.5 Market by Application
        1.5.1 Global Spinal Muscular Atrophy Market Share by Application (2013-2025)
        1.5.2 Hospital
        1.5.3 Clinic
        1.5.4 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Spinal Muscular Atrophy Market Size
    2.2 Spinal Muscular Atrophy Growth Trends by Regions
        2.2.1 Spinal Muscular Atrophy Market Size by Regions (2013-2025)
        2.2.2 Spinal Muscular Atrophy Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Spinal Muscular Atrophy Market Size by Manufacturers
        3.1.1 Global Spinal Muscular Atrophy Revenue by Manufacturers (2013-2018)
        3.1.2 Global Spinal Muscular Atrophy Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Spinal Muscular Atrophy Market Concentration Ratio (CR5 and HHI)
    3.2 Spinal Muscular Atrophy Key Players Head office and Area Served
    3.3 Key Players Spinal Muscular Atrophy Product/Solution/Service
    3.4 Date of Enter into Spinal Muscular Atrophy Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Spinal Muscular Atrophy Market Size by Type (2013-2018)
    4.2 Global Spinal Muscular Atrophy Market Size by Application (2013-2018)

5 United States
    5.1 United States Spinal Muscular Atrophy Market Size (2013-2018)
    5.2 Spinal Muscular Atrophy Key Players in United States
    5.3 United States Spinal Muscular Atrophy Market Size by Type
    5.4 United States Spinal Muscular Atrophy Market Size by Application

6 Europe
    6.1 Europe Spinal Muscular Atrophy Market Size (2013-2018)
    6.2 Spinal Muscular Atrophy Key Players in Europe
    6.3 Europe Spinal Muscular Atrophy Market Size by Type
    6.4 Europe Spinal Muscular Atrophy Market Size by Application

7 China
    7.1 China Spinal Muscular Atrophy Market Size (2013-2018)
    7.2 Spinal Muscular Atrophy Key Players in China
    7.3 China Spinal Muscular Atrophy Market Size by Type
    7.4 China Spinal Muscular Atrophy Market Size by Application

8 Japan
    8.1 Japan Spinal Muscular Atrophy Market Size (2013-2018)
    8.2 Spinal Muscular Atrophy Key Players in Japan
    8.3 Japan Spinal Muscular Atrophy Market Size by Type
    8.4 Japan Spinal Muscular Atrophy Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Spinal Muscular Atrophy Market Size (2013-2018)
    9.2 Spinal Muscular Atrophy Key Players in Southeast Asia
    9.3 Southeast Asia Spinal Muscular Atrophy Market Size by Type
    9.4 Southeast Asia Spinal Muscular Atrophy Market Size by Application

10 India
    10.1 India Spinal Muscular Atrophy Market Size (2013-2018)
    10.2 Spinal Muscular Atrophy Key Players in India
    10.3 India Spinal Muscular Atrophy Market Size by Type
    10.4 India Spinal Muscular Atrophy Market Size by Application

11 Central & South America
    11.1 Central & South America Spinal Muscular Atrophy Market Size (2013-2018)
    11.2 Spinal Muscular Atrophy Key Players in Central & South America
    11.3 Central & South America Spinal Muscular Atrophy Market Size by Type
    11.4 Central & South America Spinal Muscular Atrophy Market Size by Application

12 International Players Profiles
    12.1 Lonis Pharmaceuticals
        12.1.1 Lonis Pharmaceuticals Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Spinal Muscular Atrophy Introduction
        12.1.4 Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)
        12.1.5 Lonis Pharmaceuticals Recent Development
    12.2 F. Hoffmann-La Roche
        12.2.1 F. Hoffmann-La Roche Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Spinal Muscular Atrophy Introduction
        12.2.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2013-2018)
        12.2.5 F. Hoffmann-La Roche Recent Development
    12.3 AveXis
        12.3.1 AveXis Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Spinal Muscular Atrophy Introduction
        12.3.4 AveXis Revenue in Spinal Muscular Atrophy Business (2013-2018)
        12.3.5 AveXis Recent Development
    12.4 Novartis
        12.4.1 Novartis Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Spinal Muscular Atrophy Introduction
        12.4.4 Novartis Revenue in Spinal Muscular Atrophy Business (2013-2018)
        12.4.5 Novartis Recent Development
    12.5 Cytokinetics
        12.5.1 Cytokinetics Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Spinal Muscular Atrophy Introduction
        12.5.4 Cytokinetics Revenue in Spinal Muscular Atrophy Business (2013-2018)
        12.5.5 Cytokinetics Recent Development
    12.6 Ionis Pharmaceuticals
        12.6.1 Ionis Pharmaceuticals Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Spinal Muscular Atrophy Introduction
        12.6.4 Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)
        12.6.5 Ionis Pharmaceuticals Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details
List of Tables and Figures

    Table Spinal Muscular Atrophy Key Market Segments
    Table Key Players Spinal Muscular Atrophy Covered
    Table Global Spinal Muscular Atrophy Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Spinal Muscular Atrophy Market Size Market Share by Type 2013-2025
    Figure Early Stage Candidates Figures
    Table Key Players of Early Stage Candidates
    Figure Late Stage Candidates Figures
    Table Key Players of Late Stage Candidates
    Table Global Spinal Muscular Atrophy Market Size Growth by Application 2013-2025 (Million US$)
    Figure Hospital Case Studies
    Figure Clinic Case Studies
    Figure Others Case Studies
    Figure Spinal Muscular Atrophy Report Years Considered
    Table Global Spinal Muscular Atrophy Market Size 2013-2025 (Million US$)
    Figure Global Spinal Muscular Atrophy Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Spinal Muscular Atrophy Market Size by Regions 2013-2025 (Million US$)
    Table Global Spinal Muscular Atrophy Market Size by Regions 2013-2018 (Million US$)
    Table Global Spinal Muscular Atrophy Market Share by Regions 2013-2018
    Figure Global Spinal Muscular Atrophy Market Share by Regions 2013-2018
    Figure Global Spinal Muscular Atrophy Market Share by Regions 2018
    Table Market Top Trends
    Table Global Spinal Muscular Atrophy Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Spinal Muscular Atrophy Market Share by Manufacturers (2013-2018)
    Figure Global Spinal Muscular Atrophy Market Share by Manufacturers in 2018
    Table Global Spinal Muscular Atrophy Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Spinal Muscular Atrophy Product/Solution/Service
    Table Date of Enter into Spinal Muscular Atrophy Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
    Table Global Spinal Muscular Atrophy Market Size Share by Type (2013-2018)
    Figure Global Spinal Muscular Atrophy Market Size Market Share by Type (2013-2018)
    Table Global Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
    Table Global Spinal Muscular Atrophy Market Size Share by Application (2013-2018)
    Figure Global Spinal Muscular Atrophy Market Size Market Share by Application (2013-2018)
    Figure Global Spinal Muscular Atrophy Revenue Market Share by Application in 2017
    Figure United States Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
    Table United States Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
    Table United States Key Players Spinal Muscular Atrophy Market Share (2017-2018)
    Table United States Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
    Table United States Spinal Muscular Atrophy Market Share by Type (2013-2018)
    Table United States Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
    Table United States Spinal Muscular Atrophy Market Share by Application (2013-2018)
    Figure Europe Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
    Table Europe Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
    Table Europe Key Players Spinal Muscular Atrophy Market Share (2017-2018)
    Table Europe Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
    Table Europe Spinal Muscular Atrophy Market Share by Type (2013-2018)
    Table Europe Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
    Table Europe Spinal Muscular Atrophy Market Share by Application (2013-2018)
    Figure China Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
    Table China Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
    Table China Key Players Spinal Muscular Atrophy Market Share (2017-2018)
    Table China Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
    Table China Spinal Muscular Atrophy Market Share by Type (2013-2018)
    Table China Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
    Table China Spinal Muscular Atrophy Market Share by Application (2013-2018)
    Figure Japan Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
    Table Japan Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
    Table Japan Key Players Spinal Muscular Atrophy Market Share (2017-2018)
    Table Japan Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
    Table Japan Spinal Muscular Atrophy Market Share by Type (2013-2018)
    Table Japan Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
    Table Japan Spinal Muscular Atrophy Market Share by Application (2013-2018)
    Figure Southeast Asia Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Spinal Muscular Atrophy Market Share (2017-2018)
    Table Southeast Asia Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Spinal Muscular Atrophy Market Share by Type (2013-2018)
    Table Southeast Asia Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Spinal Muscular Atrophy Market Share by Application (2013-2018)
    Figure India Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
    Table India Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
    Table India Key Players Spinal Muscular Atrophy Market Share (2017-2018)
    Table India Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
    Table India Spinal Muscular Atrophy Market Share by Type (2013-2018)
    Table India Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
    Table India Spinal Muscular Atrophy Market Share by Application (2013-2018)
    Figure Central & South America Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Spinal Muscular Atrophy Market Share (2017-2018)
    Table Central & South America Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Spinal Muscular Atrophy Market Share by Type (2013-2018)
    Table Central & South America Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Spinal Muscular Atrophy Market Share by Application (2013-2018)
    Table Lonis Pharmaceuticals Company Details
    Table Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018) (Million US$)
    Figure Lonis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
    Table Lonis Pharmaceuticals Recent Development
    Table F. Hoffmann-La Roche Company Details
    Table F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
    Figure F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
    Table F. Hoffmann-La Roche Recent Development
    Table AveXis Company Details
    Table AveXis Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
    Figure AveXis Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
    Table AveXis Recent Development
    Table Novartis Company Details
    Table Novartis Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
    Figure Novartis Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
    Table Novartis Recent Development
    Table Cytokinetics Company Details
    Table Cytokinetics Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
    Figure Cytokinetics Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
    Table Cytokinetics Recent Development
    Table Ionis Pharmaceuticals Company Details
    Table Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
    Figure Ionis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
    Table Ionis Pharmaceuticals Recent Development
    Table Global Spinal Muscular Atrophy Market Size by Regions (Million US$) 2018-2025
    Figure Global Spinal Muscular Atrophy Market Size Share by Regions (2018-2025)
    Figure Global Spinal Muscular Atrophy Market Size Share by Regions in 2025
    Figure United States Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
    Figure China Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
    Figure India Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
    Table Global Spinal Muscular Atrophy Market Size by Product (2018-2025) (Million US$)
    Figure Global Spinal Muscular Atrophy Market Size by Product (2018-2025)
    Figure Global Spinal Muscular Atrophy Market Size by Product in 2025
    Table Global Spinal Muscular Atrophy Market Size by Application (2018-2025) (Million US$)
    Figure Global Spinal Muscular Atrophy Market Size by Application (2018-2025)
    Figure Global Spinal Muscular Atrophy Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3900
Multi User - US $7800
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify